Late last week the US Centers for Disease Control and Prevention (CDC) posted an outbreak notice about an Escherichia coli O157:H7 outbreak related to mixed leafy greens.
A retrospective study of a large cohort of US pregnancies during the COVID-19 pandemic found that infection with SARS-CoV-2 was associated with increased risks for poor pregnancy outcomes, an international team of researchers reported today in the Journal of Infectious Diseases.
The World Health Organization (WHO) announced yesterday that it has received more than $21 million from Saudi Arabia to support implementation of national antimicrobial resistance (AMR) action plans in several low- and middle-income countries.
A large study of patients in Veterans Administration (VA) hospitals shows a significant increase in the use of ceftazidime-avibactam for carbapenem-resistant Enterobacterales (CRE) infections, US researchers reported today in Infection Control & Hospital Epidemiology.
Upwards of 700,000—perhaps as many as 1.6 million—US COVID-19 survivors haven't recovered their sense of smell after more than 6 months, according to a research letter yesterday in JAMA Otolaryngology-Head & Neck Surgery.
A UK study yesterday in The Lancet finds that flu and COVID-19 vaccines can be safely co-administered.
A detailed national survey of Americans, which included residents of the four largest US metropolitan areas, found that about half of those unwilling to be vaccinated against COVID-19 were unlikely to change their minds. A research team based at Emerson University published their findings yesterday in Scientific Reports.
Yesterday, the Centers for Disease Control and Prevention (CDC) added 1 case and 3 hospitalizations to a multistate Salmonella outbreak—now at 21 cases—tied to salami sticks sold at Trader Joe's and Wegmans, and earlier this week the agency declared its investigation into a Salmonella outbreak tied to Italian-style meats over after 40 cases in 17 states.
The Centers for Disease Control and Prevention (CDC) said today that lab tests have identified a rare, potentially deadly bacterium in an aromatherapy spray.
Female sex, middle age, two or more chronic diseases, and more severe initial illness were predictive of difficulty recovering from COVID-19 6 months after release from a hospital, finds a multicenter UK study yesterday in The Lancet Respiratory Medicine.
